ON Semiconductor Corporation (Nasdaq: ONNN), driving energy efficient
innovation, today announced that total revenues in the fourth quarter of
2014 were $864.2 million, up approximately 3.7 percent compared to the
third quarter of 2014.
Beacon Roofing Supply, Inc. (the "Company") (NASDAQ: BECN) announced
results today for its first quarter ended December 31, 2014 of the
fiscal year ending September 30, 2015 (“Fiscal 2015”).
Paul Isabella, the Company’s President and Chief Executive Officer,
stated: “Fiscal 2015 is off to a solid start, as we drove record sales.
Build-A-Bear Workshop, Inc. (NYSE:BBW), today announced that it will
report results for its fiscal fourth quarter and fiscal year 2014 ended
January 3, 2015 on February 19, 2015 prior to the opening of trading on
the New York Stock Exchange.
The U.S. Army has awarded Oshkosh
Defense , LLC, an Oshkosh Corporation (NYSE: OSK) company, a base
contract plus options to reset 800 Oshkosh-produced Mine Resistant
Ambush Protected (MRAP) All-Terrain Vehicles ( M-ATVs ).
This M-ATV Reset program will help the U.S. Army achieve its goal of
standardizing the M-ATV fleet configuration and ensuring that its
primary MRAP platform is 100% mission ready following years of operation
Ignyta, Inc. (Nasdaq: RXDX), a precision oncology
biotechnology company, today announced that the U.S. Food and Drug
Administration (FDA) has granted orphan drug designation for Ignyta’s
lead product candidate entrectinib for the treatment of TrkA-positive,
TrkB-positive, TrkC-positive, ROS1-positive and ALK-positive non-small
cell lung cancer (NSCLC).
“Entrectinib has the potential to address unmet needs of patients with
rare cancers, and we will continue to aggressively pursue our clinical
development program for entrectinib in solid tumors for the benefit of
these patients,” said Jonathan Lim, M.D., Chairman and CEO of Ignyta.
Launched in celebration of Black History Month, limited-run, live weekly show seeks to pinpoint heritage and inspire through knowledge of the past Debut of the three-week series to feature Louis Gossett Jr.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.